Covestor LTD Alector, Inc. Transaction History

Covestor LTD

$160 Million
Q3 2024

A detailed history of Covestor LTD transactions in Alector, Inc. stock. As of the latest transaction made, Covestor LTD holds 14 shares of ALEC stock, worth $73. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 15 6.67%

Holding current value

$73

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$4.34 - $6.58 $4 - $6	-1 Reduced 6.67%	14 $0
Q1 2024 May 10, 2024	BUY	$5.69 - $8.08 $34 - $48	6 Added 66.67%	15 $0
Q4 2023 Feb 09, 2024	SELL	$3.77 - $8.39 $3 - $8	-1 Reduced 10.0%	9 $0
Q3 2023 Nov 13, 2023	SELL	$5.2 - $8.77 $5 - $8	-1 Reduced 9.09%	10 $0
Q4 2022 Feb 13, 2023	SELL	$6.88 - $9.55 $6 - $9	-1 Reduced 8.33%	11 $0
Q3 2022 Nov 14, 2022	SELL	$8.19 - $13.2 $24 - $39	-3 Reduced 20.0%	12 $0
Q2 2022 Aug 10, 2022	SELL	$7.65 - $14.24 $30 - $56	-4 Reduced 21.05%	15 $0
Q1 2022 May 13, 2022	BUY	$13.02 - $20.78 $26 - $41	2 Added 11.76%	19 $0
Q4 2021 Feb 10, 2022	BUY	$19.35 - $25.54 $328 - $434	17 New	17 $0

Others Institutions Holding ALEC

# of Institutions

165

Shares Held

57.9M

Call Options Held

57K

Put Options Held

14.9K

View Full List

About Alector, Inc.

Ticker ALEC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,563,904
Market Cap $433M
Description
Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...

More about ALEC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

News

Stay updated on Covestor LTD with notifications on news.

Account